Clinical Review

Testicular Cancer: Diagnosis and Treatment

Author and Disclosure Information

 

References

Conclusion

Testicular cancer is the most common cancer afflicting young men. Prompt diagnostic workup initiated in a primary care or hospital setting followed by a referral to a multidisciplinary team of urologists, medical oncologists, and radiation oncologists enables cure in a majority of patients. For patients with stage I seminoma, a radical inguinal orchiectomy followed by active surveillance may offer the best long-term outcome with minimal side effects. For patients with relapsed/refractory testicular cancers, clinical trial participation is strongly encouraged. Patients with a history of testicular cancer benefit from robust survivorship care tailored to their prior therapies. This can be safely delivered through their primary care providers in collaboration with the multidisciplinary oncology team.

Pages

Recommended Reading

ACS: Screen for colon cancer at 45
AVAHO
CT features associated with (some) ccRCC subtypes
AVAHO
No ADT-dementia link in large VA prostate cancer cohort study
AVAHO
Checkpoint inhibitor/TKI combo improves PFS of RCC over sunitinib
AVAHO
STAMPEDE: Radiation to prostate boosts survival of metastatic cancer
AVAHO
Abiraterone also benefits low-risk metastatic prostate cancer patients
AVAHO
Poor-prognosis cancers linked to highest suicide risk in first year
AVAHO
Obesity-related cancers increasing in younger adults
AVAHO
First-line avelumab/axitinib for RCC benefits wide range of patients
AVAHO
Sperm counts largely stable after adjuvant treatment of clinical stage I testicular cancer
AVAHO